Abstract
<div class="authors authors-lg"><div class="author"><div class="author-img"><img src="https://cdn.insights.bio/uploads/Kerry Ingalls-xx-sq.jpg" data-image="1"></div><div class="author-det"> <b>Kerry Ingalls</b> is Chief Operating Officer of Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure. He brings a long history of operating experience in pharmaceuticals and biotechnology. He has held numerous leadership roles including the oversight of clinical and commercial manufacturing for Amgen, leading its corporate engineering and then biologics manufacturing operations in Colorado, Ireland, California, and Puerto Rico. Ingalls has extensive professional background and training in the United States Navy spanning 30 years, including advising senior defense leaders on critical national security issues and leading elite deployed submarine operations. He received a Master of Arts in International Law and Diplomacy from Tufts University as well as a Bachelor of Science in Mechanical Engineering from the United States Naval Academy. </div></div></div>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
